Jul 16, 2026 06:14AM
Apr 27, 2026 05:21AM
Apr 20, 2026 05:00PM
Mar 23, 2026 03:11PM
Feb 25, 2026 09:35AM
Feb 25, 2026 07:04AM
Feb 24, 2026 04:29PM Supernus Pharma (SUPN) Misses Q4 EPS by 48c, provides guidance
Feb 9, 2026 11:15AM
Jan 9, 2026 07:01AM
Dec 22, 2025 07:06AM
Dec 19, 2025 07:48AM
Nov 5, 2025 10:16AM
Nov 4, 2025 05:14PM
Oct 29, 2025 06:14AM BofA Securities Starts Supernus Pharmaceuticals (SUPN) at Buy
Oct 24, 2025 08:29AM
Oct 23, 2025 06:35AM
Oct 17, 2025 07:25AM
Oct 9, 2025 12:19AM
Sep 30, 2025 06:51AM
Sep 17, 2025 04:30PM
Aug 29, 2025 06:55AM Supernus Pharmaceuticals (SUPN) PT Raised to $40 at Piper Sandler
Aug 6, 2025 10:26AM
Aug 5, 2025 04:42PM
Jul 30, 2025 07:43AM
Jul 28, 2025 08:25AM
Jun 17, 2025 09:13AM
Jun 17, 2025 06:42AM
Jun 16, 2025 07:01AM Supernus Pharma (SUPN) to Acquire Sage Therapeutics (SAGE)
May 6, 2025 04:35PM
Feb 26, 2025 09:08AM
Feb 25, 2025 04:03PM
Feb 19, 2025 12:31AM
Feb 18, 2025 04:26PM
Feb 4, 2025 11:28AM
Feb 4, 2025 11:19AM Supernus Pharmaceuticals (SUPN) PT Raised to $44 at TD Cowen
Feb 4, 2025 09:02AM
Jan 27, 2025 08:00AM
Nov 4, 2024 04:18PM
Oct 31, 2024 04:11PM
Oct 18, 2024 08:37AM
Oct 18, 2024 07:48AM
Oct 17, 2024 04:05PM Supernus Pharma (SUPN) Announces Promising Data from Open-Label Phase 2a Study of SPN-820 in Adults with Major Depressive Disorder
Sep 10, 2024 05:11PM
Aug 19, 2024 07:01AM

435,418 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All